WO2017184227A3 - Recombinase genome editing - Google Patents

Recombinase genome editing Download PDF

Info

Publication number
WO2017184227A3
WO2017184227A3 PCT/US2017/016184 US2017016184W WO2017184227A3 WO 2017184227 A3 WO2017184227 A3 WO 2017184227A3 US 2017016184 W US2017016184 W US 2017016184W WO 2017184227 A3 WO2017184227 A3 WO 2017184227A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell
nucleic acid
recombinase
genome editing
providing
Prior art date
Application number
PCT/US2017/016184
Other languages
French (fr)
Other versions
WO2017184227A2 (en
Inventor
George M. Church
Christopher J. Gregg
Marc J. Lajoie
Xavier RIOS
Original Assignee
President And Fellows Of Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201662291499P priority Critical
Priority to US62/291,499 priority
Priority to US201662315336P priority
Priority to US62/315,336 priority
Application filed by President And Fellows Of Harvard College filed Critical President And Fellows Of Harvard College
Publication of WO2017184227A2 publication Critical patent/WO2017184227A2/en
Publication of WO2017184227A3 publication Critical patent/WO2017184227A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1058Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups

Abstract

A method of altering a target nucleic acid sequence within a cell is provided including providing the cell with a donor nucleic acid, providing the cell with a single strand annealing protein, and providing the cell with a single strand DNA binding protein, wherein one or more or both of the single strand annealing protein and the single strand DNA binding protein is foreign to the cell, and wherein the donor nucleic acid is recombined into the target nucleic acid.
PCT/US2017/016184 2016-02-04 2017-02-02 Recombinase genome editing WO2017184227A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US201662291499P true 2016-02-04 2016-02-04
US62/291,499 2016-02-04
US201662315336P true 2016-03-30 2016-03-30
US62/315,336 2016-03-30

Publications (2)

Publication Number Publication Date
WO2017184227A2 WO2017184227A2 (en) 2017-10-26
WO2017184227A3 true WO2017184227A3 (en) 2018-02-08

Family

ID=60116930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/016184 WO2017184227A2 (en) 2016-02-04 2017-02-02 Recombinase genome editing

Country Status (1)

Country Link
WO (1) WO2017184227A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020237066A2 (en) * 2019-05-23 2020-11-26 President And Fellows Of Harvard College Gene editing in diverse bacteria
WO2020264016A1 (en) 2019-06-25 2020-12-30 Inari Agriculture, Inc. Improved homology dependent repair genome editing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144734B2 (en) * 2000-08-14 2006-12-05 The United States Of America As Represented By The Department Of Health And Human Services Enhanced homologous recombination mediated by lambda recombination proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144734B2 (en) * 2000-08-14 2006-12-05 The United States Of America As Represented By The Department Of Health And Human Services Enhanced homologous recombination mediated by lambda recombination proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANTONY ET AL.: "Multiple C-terminal tails within a single E. coli SSB homotetramer coordinate DNA replication and repair", J MOL BIO, vol. 425, no. 23, 2013, pages 4802 - 4819, XP028766573 *
DATABASE GenBank [O] 2 April 2015 (2015-04-02), "single-stranded DNA-binding protein [Escherichia coli K-12]", XP055462012, Database accession no. CQR83440.1. *
DATABASE GenBank [O] 26 November 2012 (2012-11-26), "hypothetical protein PA39016_003090055 [Pseudomonas aeruginosa 39016]", XP055462020, Database accession no. ZP 07797103.1 *
DATABASE GenBank 8 February 2016 (2016-02-08), "phage recombination protein Bet [Pseudomonas aeruginosa]", XP055462028, Database accession no. WP_003088368.1 *
MEYER ET AL.: "The single-stranded DNA-binding protein of Escherichia coli", MICROBIOL REV, vol. 54, no. 4, 1990, pages 342 - 380, XP055462010 *

Also Published As

Publication number Publication date
WO2017184227A2 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
WO2017184786A8 (en) Cpf1 complexes with reduced indel activity
BR112018076190A2 (en) orthologs and crispr type vi systems
WO2017070626A3 (en) Respiratory virus vaccines
WO2015138510A8 (en) Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
EP3161700A4 (en) Processes and systems for nucleic acid sequence assembly
WO2015071474A3 (en) Crispr-cas system materials and methods
WO2015200334A4 (en) Nuclease-mediated dna assembly
EP3496202A4 (en) Solid electrolyte material, and cell
SG10201805815YA (en) Rna-guided gene drives
WO2017011580A3 (en) Anti-pd-1 antibodies, activatable anti-pd-1 antibodies, and methods of use thereof
EP3532075A4 (en) Viral methods of making genetically modified cells
EP3452591A4 (en) Macromolecule analysis employing nucleic acid encoding
EP3633032A3 (en) Novel cas9 proteins and guiding features for dna targeting and genome editing
EP3337909A4 (en) Methods and reagents for molecular proximity detection using rna-guided nucleic acid binding proteins
IL254554D0 (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
WO2015052231A3 (en) Multiplex editing system
WO2015013583A3 (en) Genome engineering
EP3500670A4 (en) Novel crispr enzymes and systems
IL265598D0 (en) Rna-guided nucleic acid modifying enzymes and methods of use thereof
EP3377657A4 (en) Transformable tagging compositions, methods, and processes incorporating same
WO2015077290A3 (en) Large gene excision and insertion
EP3294342A4 (en) Universal donor stem cells and related methods
WO2015048342A3 (en) Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
ECSP14028704A (en) METHODS AND COMPOSITIONS FOR RNA-DIRECTED MODIFICATION OF TARGET DNA AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
WO2017127807A8 (en) Crystal structure of crispr cpf1

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17786273

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17786273

Country of ref document: EP

Kind code of ref document: A2